Short Papers
Infection of an Aortic Prosthesis Caused by Duodenal Erosion [Abridged] by R E B Tagart Mch FRcs (Newmarket General Hospital, Newmarket, Suffolk, CB8 7JG) Case Report A bifurcated Dacron aortic prosthesis, inserted to replace an abdominal aortic aneurysm, became infected four months after insertion, causing klebsiella septicamia. At a second operation, performed eight months after the first, the cause of the infection was found to be erosion of the posterior wall of the third part of the duodenum by the left limb of the prosthesis, which was deeply bile stained and occluded by infected blood clot. The left limb of the prosthesis was removed and the duodenal opening repaired with a two-layer suture. At first this measure seemed to be successful but Gram-negative septicemia recurred and the patient died from this twelve months after the first operation. Post-mortem examination revealed klebsiella infection in the remaining prosthesis. The duodenum was intact.
Discussion
Early postoperative infection of a prosthesis may be due to: (1) Inadequate aseptic technique. (2) Contamination of the operative field by illadvised concomitant operations on the alimentary tract such as appendicectomy or vagotomy and pyloroplasty. (3) Pre-existing infection in an aortic aneurysm (Somerville et al. 1959 found in a post-mortem study that 6 out of 178 aneurysms were infected). (4) Bacteremia caused by the passing of a urethral catheter or an endotracheal tube. Kotin (1952) found that even such ordinary procedures as eating or brushing the teeth could cause bacternmia.
The last two causes listed above may provide a rational basis for the use of preoperative systemic antibiotics although their value is by no means proved and they may even increase the incidence of postoperative infection. Late postoperative infection is less easily explained. Yashar & Yashar (1972) reported that prosthesis infection was the cause of 2 'late deaths' among 113 survivors of abdominal aortic reconstruction. Aorto-enteric fistula occurs usually at a vascular suture line. The clinical picture is dominated by intestinal hemorrhage rather than by signs of infection. This complication may occur as late as six years after the operation (Lise & Yacoub 1969) . Adequate prophylaxis against this complication should be achieved if suture lines are protected by Dacron sleeves cut from the prosthesis and slipped over them. Intestinal erosion, as reported here, is a rareor rarely recognizedcause of late graft infection. Reports of only 4 similar cases have been found (Youmans & Derrick 1967 , De Weese & Fry 1962 . It has been diagnosed by the recognition of a radiological 'coiled spring sign' caused by a coating of barium sulphate on the corrugated surface of the graft.
The interposition of a protective layer between prosthesis and duodenum is recommended. This may be part of the wall of an aneurysm or, if this is not available, a piece of greater omentum passed backwards through an opening in the transverse mesocolon to the left of the middle colic artery (Sproul 1962 , Dietrich et al. 1966 .
Treatment
This case report shows, and the subsequent discussion confirmed, that removal of part of an infected graft is not enough, even though the cause of the infection is at the same time eliminated. The whole of the prosthesis must be removed. Pain, jaundice and loss of weight are the most frequent presenting symptoms of cancer of the pancreas. Jaundice can be relieved by surgical intervention and this will increase the length of survival of patients. However, pain occurs at some time during the course of the illness in 80 % -of patients and, when it occurs at an early stage of the disease, it persists not only as a major symptom but as an ominous sign (Braganza & Howat 1972) . The use of intra-arterial chemotherapy primarily for the relief of pain has been explored in this neoplasm and those of the liver, biliary tree and gall-bladder.
Intra

Method
During the period 1968-73, a selected series of 112 patients with upper gastrointestinal neoplasms have been treated by percutaneous femoral intra-arterial cceliac axis infusion with anticancer drugs. The technique used consists essentially of inserting an arterial catheter, as for a coeliac angiogram, but placing the tip preferentially into the common hepatic artery. The catheter is then connected to a constant infusion pump (Gazet 1973) . The catheter may require adjustment, and this is the most frequent complication. 5-fluorouracil (5-FU) has been the drug of choice in a dose of 15 mg/kg per day or I g/day (whichever is the greater dose) for a period of five days. Each 0.5 g of 5-FU is added to 500 ml of normal saline containing 500 units of heparin and infused over 12 hours. In the last 23 infusions, pulsed doses of I g cyclophosphamide, 2 mg vincristine and 50 mg methotrexate have been added.
Usually prophylactic ampicillin 250 mg 6 hourly for 5 days has been given at the same time. Following catheter removal, intravenous maintenance therapy of 1 g of 5-FU has been given weekly when possible for three months. In some patients a second infusion has been given. Only 3 patients have had toxic symptoms from drug therapy. All patients have had preand postinfusion liver function tests, repeated thereafter as appropriate. A full blood count has been performed pre-infusion, daily during infusion. and twice weekly thereafter for two weeks, then once weekly during intravenous therapy.
Results
Of 65 patients who had pancreatic carcinoma 14 were noted to have secondary deposits in the liver at the time of exploration. All were incurable. Six patients had a previous palliative resection and now had recurrent disease. Of the patients referred for a second opinion, 20 had a further exploration, but of these only 3 had a palliative procedure performed. By 31 December 1973, 53 had died, 12 were still alive.
Survival in the 53 patients now dead has varied from 4 to 944 days infusion with a median survival of 143 days and mean survival of 192 days. The survival from the date of operation or proof of incurability has varied from 20 to 964 days with a median survival of 196 days and mean survival of 265 days. Pain was a primary symptom in 46 of these patients, and was graded arbitrarily on a scale of 0-10; no pain was equal to zero (0) and intolerable pain was given a score of 10 (T F R Pilkington 1969, personal communication). All scored the severity of pain pre-infusion above 5 (intolerable pain). At one week from the commencement of treatment, the severity of pain was less. By one to three months after treatment, there was a tendency for the severity of the pain to increase or recur. This has been calculated alternatively as the percentage of patients suffering intolerable (5 +) or tolerable (5-) pain in the three periods noted. At one week post-infusion 66% had tolerable and 34% intolerable pain; whereas at 1-3 months post-infusion, the ratio was 50 % each group. Taking complete or mark7ed improvement in pain as a group, then 54.1 % of patients had a worth-while relief of symptoms with a recurrence of pain in less than a third of the group. In other words, 37.5 % of patients with intolerable pain had complete and permanent relief of symptoms until death. At 31.12.73, 12 patients had survived from 28 to 1297 days. In 8 the primary symptom was pain; one patient had a marked improvement of symptoms and 5 others had some benefit.
Conclusions
Despite isolated reports on the disappearance of hepatic cancer after intra-arterial chemotherapy (Anderson et al. 1972 ) the limitations of this therapy must be appreciated. Terminal patients
